Recent studies have shown that NPs not only have the advantages of wide availability, high biocompatibility and low toxicity, but also can synergistically regulate glucose metabolism through multiple pathways such as improving INS sensitivity, protecting pancreatic β-cells and inhibiting chronic inflammation, as a result of which they are regarded as a breakthrough candidate for diabetes intervention [3]. The gene discussed is INS; the disease is diabetes mellitus.